Inhibitor screening for volume-sensitive LRRC8A chloride channel

Author:

Liu Chao12,Cui Wenqiang3,Zhu Kongfu1,Yuan Shuguang3,Sun Liang4,Liang Yujie5,Lu Jianping5,Li Da2,Deng Zhiqin6,Duan Li7,Zhang Weiming1,Yu Xiaohai1,Wang Daping17,Zhang Huawei23

Affiliation:

1. Department of Computer Science, School of Artificial Intelligence, Dongguan City University, Dongguan, China

2. Department of Biomedical Engineering,Southern University of Science and Technology, Shenzhen, China

3. Research Center for Computer-Aided Drug Discovery, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China

4. Shenzhen Shuli Tech Co., Ltd, Shenzhen, China

5. Department of Child and Adolescent Psychiatry, Shenzhen Kangning Hospital, Shenzhen Mental Health Center, Shenzhen, China

6. Hand and Foot Surgery Department, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China

7. Department of Orthopedics, Shenzhen Intelligent Orthopaedics and Biomedical Innovation Platform, Guangdong Provincial Research Center for Artificial Intelligence and Digital Orthopedic Technology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China

Funder

National Natural Science Foundation of China

Guangdong Provincial Key Laboratory of Advanced Biomaterials

Center for Computational Science and Engineering at Southern University of Science and Technology

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3